Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-08-16 Purchase |
2022-08-18 4:05 pm |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY President & CEO |
40,000 | $0.96 | $38,400 | 333,212 (Direct) |
View |
2022-03-16 Purchase |
2022-03-17 9:26 pm |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
50,000 | $1.283 | $64,150 | 293,212 (Direct) |
View |
2021-03-19 Purchase |
2021-03-22 5:17 pm |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
11,000 | $4.7911 | $52,702 | 113,698 (Direct) |
View |
2021-03-08 Sale |
2021-03-12 4:35 pm |
Oxford Immunotec Global PLC | OXFD | ANDREWS RONALD ASBURY Director |
4,081 | $22 | $89,782 | 0 (Direct) |
View |
2020-08-03 Purchase |
2020-08-04 6:50 pm |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
40,000 | $1.347 | $53,880 | 102,698 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-15 Option Award |
2025-04-17 5:02 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
1,785 | $5.6 | 14,552 (Direct) |
View |
2025-01-14 Option Award |
2025-01-16 5:17 pm |
N/A 2035-01-14 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
1,000 | $0 | 1,000 (Direct) |
View |
2025-01-15 Option Award |
2025-01-16 5:15 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
1,639 | $6.1 | 12,767 (Direct) |
View |
2024-10-15 Option Award |
2024-10-17 4:34 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
1,510 | $6.62 | 11,128 (Direct) |
View |
2024-08-31 Option Award |
2024-09-06 5:11 pm |
N/A 2031-03-01 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
3,611 | $0 | 3,611 (Direct) |
View |
2024-07-15 Option Award |
2024-07-16 4:30 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
2,157 | $4.63 | 9,618 (Direct) |
View |
2024-06-21 Option Award |
2024-06-25 5:02 pm |
N/A 2034-06-21 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
1,000 | $0 | 1,000 (Direct) |
View |
2024-04-15 Option Award |
2024-04-17 4:21 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
3,153 | $6.66 | 7,461 (Direct) |
View |
2023-10-24 Option Award |
2023-10-26 4:30 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
4,005 | $0 | 4,308 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:39 pm |
N/A N/A |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
6,060 | $0 | 6,060 (Direct) |
View |
2023-01-06 Option Award |
2023-01-10 4:42 pm |
N/A 2033-01-06 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
30,000 | $0 | 30,000 (Direct) |
View |
2022-12-07 Option Award |
2022-12-09 8:23 pm |
N/A 2032-12-07 |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Former CEO |
50,000 | $0 | 1,164,462 (Direct) |
View |
2022-12-01 Exercise |
2022-12-09 8:23 pm |
N/A N/A |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Former CEO |
250,000 | $0 | 1,164,462 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 9:24 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
1,410,000 | $0 | 1,410,000 (Direct) |
View |
2022-01-11 Option Award |
2022-01-13 5:05 pm |
N/A 2032-01-11 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-08-03 Option Award |
2021-08-05 5:35 pm |
N/A 2031-08-03 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
25,000 | $0 | 25,000 (Direct) |
View |
2021-07-01 Tax Withholding |
2021-07-02 9:32 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
15,834 | $0 | 243,212 (Direct) |
View |
2021-07-01 Exercise |
2021-07-02 9:32 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
65,000 | $0 | 243,212 (Direct) |
View |
2021-06-30 Tax Withholding |
2021-07-02 1:59 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
25,873 | $0 | 194,046 (Direct) |
View |
2021-05-07 Exercise |
2021-07-02 1:59 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
106,221 | $0 | 194,046 (Direct) |
View |
2021-03-01 Option Award |
2021-03-04 3:08 pm |
N/A 2031-03-01 |
Precipio Inc. | PRPO | ANDREWS RONALD ASBURY Director |
7,240 | $0 | 2,074 (Direct) |
View |
2021-02-25 Option Award |
2021-03-01 4:28 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
500,000 | $5.34 | 500,000 (Direct) |
View |
2020-06-24 Option Award |
2020-06-26 4:05 pm |
N/A 2030-06-24 |
Oxford Immunotec Global PLC | OXFD | ANDREWS RONALD ASBURY Director |
13,575 | $0 | 13,575 (Direct) |
View |
2020-05-07 Option Award |
2020-05-12 2:25 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
106,221 | $0 | 106,221 (Direct) |
View |